These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10448596)

  • 1. Quality control of flow cytometric immunophenotyping of haematological malignancies.
    Gratama JW; Bolhuis RL; Van 't Veer MB
    Clin Lab Haematol; 1999 Jun; 21(3):155-60. PubMed ID: 10448596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
    Kalina T; Flores-Montero J; van der Velden VH; Martin-Ayuso M; Böttcher S; Ritgen M; Almeida J; Lhermitte L; Asnafi V; Mendonça A; de Tute R; Cullen M; Sedek L; Vidriales MB; Pérez JJ; te Marvelde JG; Mejstrikova E; Hrusak O; Szczepański T; van Dongen JJ; Orfao A;
    Leukemia; 2012 Sep; 26(9):1986-2010. PubMed ID: 22948490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.
    van Dongen JJ; Lhermitte L; Böttcher S; Almeida J; van der Velden VH; Flores-Montero J; Rawstron A; Asnafi V; Lécrevisse Q; Lucio P; Mejstrikova E; Szczepański T; Kalina T; de Tute R; Brüggemann M; Sedek L; Cullen M; Langerak AW; Mendonça A; Macintyre E; Martin-Ayuso M; Hrusak O; Vidriales MB; Orfao A;
    Leukemia; 2012 Sep; 26(9):1908-75. PubMed ID: 22552007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies.
    Ruiz-Argüelles A; Rivadeneyra-Espinoza L; Duque RE; Orfao A;
    Cytometry B Clin Cytom; 2006 Jan; 70(1):39-44. PubMed ID: 16353215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group Experience.
    Solly F; Angelot-Delettre F; Ticchioni M; Geneviève F; Rambaud H; Baseggio L; Plesa A; Debliquis A; Garnache-Ottou F; Roggy A; Campos L; Aanei C; Rosenthal-Allieri A; Georget MT; Lachot S; Jacob MC; Robillard N; Wuilleme S; Andre-Kerneis E; Cornet E; Salaun V; Bennami H; Lhoumeau AC; Arnoulet C; Jacqmin H; Neyman N; Latger-Cannard V; Massin F; Lainey E; Le Garff-Tavernier M; Costopoulos M; Roussel M; Mayeur-Rousse C; Eischen A; Raggeneau V; Derrieux C; Maurer M; Asnafi V; Trinquand A; Brouzes C; Lhermitte L
    Cytometry A; 2019 Sep; 95(9):1008-1018. PubMed ID: 31364809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON).
    van Wering ER; van Lochem EG; Leenders M; van der Sluijs-Gelling AJ; Wind H; Gratama JW; Kraan J; Preijers FW
    J Biol Regul Homeost Agents; 2004; 18(3-4):313-26. PubMed ID: 15786698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and quality control of immunophenotyping in clinical flow cytometry.
    Owens MA; Vall HG; Hurley AA; Wormsley SB
    J Immunol Methods; 2000 Sep; 243(1-2):33-50. PubMed ID: 10986405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Belgian consensus recommendations for flow cytometric immunophenotyping. The Belgian Association for Cytometry/Belgische Vereniging voor Cytometrie/Association Belge de Cytométrie.
    Van Bockstaele DR; Deneys V; Philippé J; Bernier M; Kestens L; Chatelain B; De Waele M; Demanet C
    Acta Clin Belg; 1999 Apr; 54(2):88-98. PubMed ID: 10394646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in the immunophenotypic analysis of haematological malignancies.
    Heel K; Tabone T; Röhrig KJ; Maslen PG; Meehan K; Grimwade LF; Erber WN
    Blood Rev; 2013 Jul; 27(4):193-207. PubMed ID: 23845589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A teaching database for diagnosis of hematologic neoplasms using immunophenotyping by flow cytometry.
    Nguyen AN; De J; Nguyen J; Padula A; Qu Z
    Arch Pathol Lab Med; 2008 May; 132(5):829-37. PubMed ID: 18466042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control in clinical flow cytometry.
    Oldaker TA
    Clin Lab Med; 2007 Sep; 27(3):671-85, viii. PubMed ID: 17658412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than just quality control.
    Carey JL; Oldaker TA
    Clin Lab Med; 2007 Sep; 27(3):687-707, ix. PubMed ID: 17658413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Control of Immunophenotyping.
    Greig B
    Methods Mol Biol; 2019; 2032():227-279. PubMed ID: 31522423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
    Orfao A; Schmitz G; Brando B; Ruiz-Arguelles A; Basso G; Braylan R; Rothe G; Lacombe F; Lanza F; Papa S; Lucio P; San Miguel JF
    Clin Chem; 1999 Oct; 45(10):1708-17. PubMed ID: 10508115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
    Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance.
    Kluin-Nelemans J; Van Wering E; Van Der Schoot C; Adriaansen H; Van'T Veer M; Van Dongen J; Gratama J;
    Br J Haematol; 2001 Feb; 112(2):337-43. PubMed ID: 11167826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British Committee for Standards in Haematology.
    Johansson U; Bloxham D; Couzens S; Jesson J; Morilla R; Erber W; Macey M;
    Br J Haematol; 2014 May; 165(4):455-88. PubMed ID: 24620735
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduction of interlaboratory variability in flow cytometric immunophenotyping by standardization of instrument set-up and calibration, and standard list mode data analysis.
    Gratama JW; Kraan J; Adriaansen H; Hooibrink B; Levering W; Reinders P; Van den Beemd MW; Van der Holt B; Bolhuis RL
    Cytometry; 1997 Feb; 30(1):10-22. PubMed ID: 9056737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External quality assessment in clinical cell analysis by flow cytometry. Why is it so important?
    Siftar Z; Paro MM; Sokolić I; Nazor A; Mestrić ZF
    Coll Antropol; 2010 Mar; 34(1):207-17. PubMed ID: 20432753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.